There is currently no cure for HSV-1 or HSV-2. Current treatments, like acyclovir and valacyclovir, can help alleviate symptoms and lower transmission risk, but do not cure the virus from the body. Herpes lurks in a latent state in nerve cells and other body compartments, making it hard to treat with the usual medications or the immune system.
But 2025 is a potential pivot point. Advances in ACC multiple individual late-stage developments gene editing technology, including promising meganucleases from Fred Hutchinson Cancer Research Centre, have led to more than 90% reduction of the virus in animal models. And new antivirals, including IM-250 and ABI-5366, are being tested and may provide better suppression and fewer recurrences.
Therapeutic and mRNA-based vaccines are being developed on the vaccine side, with early trials demonstrating promising immune responses. Though these therapies are not yet available to the public, they represent significant steps toward a functional cure, with the potential to one day suppress outbreaks and transmission permanently.
In short, they have not found a cure yet in 2025, though there have been. AdvertisementGradife and Luis discovered the vaccine has served them well since they got it. Hell, it has to become expedient to guarantee himself a spot in the JagDome. The cure may not be here yet, but it is finally within our grasp.
How Close Are We to Curing Herpes?
More than ever, in 2025, we are on the cusp of curing herpes, even though we aren’t quite there yet. Promising gene-editing breakthroughs, such as those devised by Fred Hutchinson scientists, have wiped out more than 90% of the virus from animal models.
New antivirals, including IM-250 and ABI-5366, are under investigation in humans and present the possibility of more profound suppression of HSV. Moreover, therapeutic mRNA vaccines are in development to teach the immune system to regulate or kill the virus.
Although not a cure just yet, these advancements provide promise that a functional or full cure may be on the way within a few years.
What is the June 2025 Herpes Cure?
Among the advances as of June 2025, the most significant is the development of IM-250, a novel oral helicase-primase inhibitor that is administered once a week. -Click Therapeutics of New York announced the enrollment of the Phase trial of its safety, pharmacokinetics and efficacy study in treating recurrent genital herpes outbreaks.
Secondly, also at ESCMID 2025, ABI‑5366 (Assembly Biosciences), a further long‑acting helicase-primase inhibitor, presented early data suggesting that monthly dosing may be a feasible option to suppress viral activity and latency.
These advances are not a definitive cure, but they certainly represent a departure from the symptomatic viral shedding we currently manage daily, to malignant virus suppression, possibly even eradicating the latent HSV pool.
Will You Ever Be Able to Get Rid of Herpes?
Although there is no cure for genital herpes, medication can help manage and reduce the severity of symptoms. Medication can also reduce the frequency of further infections and the spread of the virus.
